Upgrades:
Dominion Energy (NYSE:D) was upgraded by The Goldman Sachs Group from a "sell" rating to a "neutral" rating in a note issued to investors on Sunday, The Fly reports.
A number of other brokerages also recently weighed in on D.
BMO Capital Markets lifted their price target on Dominion Energy from $72.00 to
$76.00 and gave the company an "outperform" rating in a report on
Monday, November 7th. Maxim Group assumed coverage on Dominion Energy in a
report on Friday, November 4th. They set a "hold" rating on the
stock. Seaport Res Ptn reiterated a "neutral" rating on shares of
Dominion Energy in a report on Thursday, October 6th. Wolfe Research downgraded
Dominion Energy from an "outperform" rating to a "peer
perform" rating in a report on Monday, November 7th. Finally, Barclays
lowered their price target on Dominion Energy from $93.00 to $86.00 and set an
"equal weight" rating on the stock in a report on Monday, July 18th.
One equities research analyst has rated the stock with a sell rating, eleven
have given a hold rating and three have assigned a buy rating to the company.
Based on data from MarketBeat, the stock presently has a consensus rating of
"Hold" and an average target price of $75.33. Read
more …
Medical Properties Trust (NYSE:MPW) was upgraded by analysts at Bank of America from a "neutral" rating to a "buy" rating in a research note issued on Monday, The Fly reports. The analysts noted that the move was a valuation call.
Several other brokerages have also recently weighed in on
MPW. Royal Bank of Canada dropped their price target on shares of Medical
Properties Trust from $20.00 to $18.00 in a research report on Tuesday, October
4th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of
Medical Properties Trust from $17.00 to $15.00 and set a "hold"
rating on the stock in a research report on Friday, September 16th. Barclays
decreased their price objective on shares of Medical Properties Trust from
$23.00 to $19.00 and set an "overweight" rating for the company in a
research note on Friday, October 21st. StockNews.com initiated coverage on shares
of Medical Properties Trust in a research note on Wednesday, October 12th. They
issued a "hold" rating for the company. Finally, Raymond James
decreased their price objective on shares of Medical Properties Trust from
$20.00 to $18.00 and set a "strong-buy" rating for the company in a
research note on Thursday, September 22nd. Six investment analysts have rated
the stock with a hold rating, four have assigned a buy rating and one has
assigned a strong buy rating to the stock. According to data from MarketBeat, Medical
Properties Trust presently has a consensus rating of "Moderate Buy"
and an average price target of $17.91. Read
more …
Ritchie Bros. Auctioneers (NYSE:RBA) (TSE:RBA) was upgraded by equities researchers at Northcoast Research from a "neutral" rating to a "buy" rating in a research note issued on Monday, The Fly reports. The firm currently has a $65.00 price objective on the business services provider's stock. Northcoast Research's price target would indicate a potential upside of 18.53% from the company's previous close.
A number of other equities analysts have also commented on
RBA. Raymond James cut their price target on Ritchie Bros. Auctioneers from
$62.00 to $55.00 and set a "market perform" rating for the company in
a report on Tuesday, November 8th. OTR Global reaffirmed a "negative"
rating on shares of Ritchie Bros. Auctioneers in a report on Wednesday,
November 2nd. National Bankshares raised Ritchie Bros. Auctioneers from an
"underperform" rating to a "sector perform" rating and cut
their price target for the stock from $60.00 to $55.00 in a report on Tuesday,
November 8th. Scotiabank cut their price target on Ritchie Bros. Auctioneers
from $68.00 to $64.00 in a report on Wednesday, October 5th. Finally,
StockNews.com began coverage on Ritchie Bros. Auctioneers in a research note on
Wednesday, October 12th. They set a "buy" rating for the company. One
investment analyst has rated the stock with a sell rating, five have assigned a
hold rating and four have assigned a buy rating to the company. Based on data
from MarketBeat.com, the company currently has a consensus rating of
"Hold" and a consensus target price of $59.67. Read
more …
Argus upgraded shares of Philip Morris International (NYSE:PM) from a hold rating to a buy rating in a research note published on Tuesday, MarketBeat.com reports. The brokerage currently has $110.00 price objective on the stock.
A number of other brokerages also recently weighed in on PM.
Stifel Nicolaus reduced their price target on shares of Philip Morris
International from $115.00 to $105.00 and set a buy rating for the company in a
report on Friday, October 14th. StockNews.com raised shares of Philip Morris
International from a hold rating to a buy rating in a report on Monday, October
31st. Jefferies Financial Group reduced their price target on shares of Philip
Morris International from $107.00 to $99.00 in a report on Tuesday, July 19th.
Morgan Stanley increased their price target on shares of Philip Morris
International from $102.00 to $109.00 and gave the company an overweight rating
in a report on Wednesday, November 2nd. Finally, Credit Suisse Group reduced
their price target on shares of Philip Morris International to $95.00 in a
report on Thursday, October 27th. Five analysts have rated the stock with a
hold rating and four have issued a buy rating to the company. Based on data
from MarketBeat.com, the company presently has an average rating of Hold and an
average target price of $107.50. Read
more …
Xylem (NYSE:XYL) was upgraded by Atlantic Securities from a "neutral" rating to an "overweight" rating in a report issued on Wednesday, The Fly reports. The firm currently has a $129.00 price target on the industrial products company's stock, up from their prior price target of $110.00. Atlantic Securities' price objective indicates a potential upside of 15.05% from the stock's current price.
Other analysts have also recently issued research reports
about the company. Mizuho raised their target price on Xylem from $80.00 to
$88.00 and gave the stock a "neutral" rating in a research report on
Wednesday, August 3rd. Morgan Stanley upped their target price on shares of
Xylem from $100.00 to $105.00 and gave the company an "overweight"
rating in a research report on Thursday, November 3rd. Cowen increased their
target price on Xylem from $105.00 to $115.00 in a report on Wednesday,
November 2nd. StockNews.com began coverage on shares of Xylem in a research
note on Wednesday, October 12th. They issued a "hold" rating for the
company. Finally, TheStreet cut shares of Xylem from a "b-" rating to
a "c" rating in a research note on Tuesday, November 1st. Eight
investment analysts have rated the stock with a hold rating and six have given
a buy rating to the company. According to data from MarketBeat, the stock
presently has an average rating of "Hold" and an average target price
of $109.36. Read
more …
Pinnacle West Capital (NYSE:PNW) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating in a research note issued on Thursday, The Fly reports.
Several other analysts also recently issued reports on the
company. KeyCorp cut their price objective on Pinnacle West Capital from $62.00
to $56.00 and set an "underweight" rating on the stock in a report on
Thursday, October 20th. StockNews.com assumed coverage on Pinnacle West Capital
in a report on Wednesday, October 12th. They issued a "hold" rating
on the stock. Morgan Stanley upped their target price on Pinnacle West Capital
from $62.00 to $67.00 and gave the company an "equal weight" rating
in a report on Friday, November 11th. TheStreet raised Pinnacle West Capital
from a "c+" rating to a "b" rating in a research note on
Thursday, August 18th. Finally, Wells Fargo & Company boosted their price
target on Pinnacle West Capital from $69.00 to $70.00 and gave the company an "equal
weight" rating in a research note on Friday, November 4th. Five analysts
have rated the stock with a sell rating and six have given a hold rating to the
company. According to MarketBeat, the company has a consensus rating of
"Hold" and a consensus price target of $68.92. Read
more …
NVIDIA (NASDAQ:NVDA) was upgraded by research analysts at Summit Insights from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat.com reports.
Other analysts have also issued research reports about the
stock. Benchmark lowered their price target on shares of NVIDIA from $228.00 to
$215.00 and set a “buy” rating for the company in a report on Thursday, August
25th. Stifel Nicolaus began coverage on shares of NVIDIA in a research report
on Wednesday, September 7th. They set a “hold” rating and a $165.00 price
target on the stock. Jefferies Financial Group cut their price objective on
shares of NVIDIA from $370.00 to $280.00 in a research report on Thursday,
August 25th. JPMorgan Chase & Co. cut their price target on shares of
NVIDIA from $230.00 to $220.00 in a research report on Thursday, August 25th.
Finally, Oppenheimer cut their price target on shares of NVIDIA from $250.00 to
$225.00 and set an “outperform” rating on the stock in a research report on
Friday, November 11th. One research analyst has rated the stock with a sell
rating, nine have given a hold rating, twenty-five have given a buy rating and
one has assigned a strong buy rating to the company. According to MarketBeat,
the company presently has an average rating of “Moderate Buy” and an average
price target of $210.21. Read
more …
Walgreens Boots Alliance (NASDAQ:WBA) was upgraded by equities research analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research report issued to clients and investors on Friday, The Fly reports.
A number of other brokerages also recently weighed in on
WBA. UBS Group lowered their price objective on shares of Walgreens Boots
Alliance from $40.00 to $37.00 and set a "neutral" rating on the
stock in a research report on Friday, October 7th. Mizuho reduced their target
price on shares of Walgreens Boots Alliance to $36.00 in a report on Thursday,
October 13th. Royal Bank of Canada reduced their target price on shares of
Walgreens Boots Alliance from $42.00 to $36.00 and set a "sector
perform" rating for the company in a report on Wednesday, October 19th.
Deutsche Bank Aktiengesellschaft raised shares of Walgreens Boots Alliance from
a "hold" rating to a "buy" rating and upped their target
price for the company from $41.00 to $50.00 in a report on Friday, November
11th. Finally, Truist Financial upped their target price on shares of Walgreens
Boots Alliance from $38.00 to $44.00 in a report on Tuesday, November 8th. One
research analyst has rated the stock with a sell rating, nine have given a hold
rating and two have assigned a buy rating to the company. Based on data from
MarketBeat.com, the stock presently has an average rating of "Hold"
and a consensus price target of $42.77. Read
more …
Domino's Pizza (NYSE:DPZ) was upgraded by research analysts at Northcoast Research from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Friday, Marketbeat reports. The brokerage currently has a $460.00 price objective on the restaurant operator's stock. Northcoast Research's price target points to a potential upside of 25.43% from the company's current price.
DPZ has been the subject of a number of other research
reports. Cowen reduced their price target on Domino's Pizza from $410.00 to
$362.00 and set a "market perform" rating for the company in a report
on Tuesday, September 27th. Wedbush increased their price target on Domino's
Pizza from $370.00 to $400.00 in a report on Friday, October 14th. Morgan
Stanley reduced their price target on Domino's Pizza from $426.00 to $373.00
and set an "equal weight" rating for the company in a report on
Tuesday, October 11th. BMO Capital Markets reduced their price target on
Domino's Pizza from $430.00 to $400.00 and set an "outperform" rating
for the company in a report on Friday, October 14th. Finally, Bank of America
reduced their price target on Domino's Pizza from $512.00 to $490.00 and set a "buy"
rating for the company in a report on Friday, July 22nd. Two analysts have
rated the stock with a sell rating, fourteen have issued a hold rating and
eight have given a buy rating to the company. Based on data from
MarketBeat.com, Domino's Pizza currently has a consensus rating of
"Hold" and a consensus target price of $408.38. Read
more …
Downgrades:
Algonquin Power & Utilities (NYSE:AQN) was downgraded by investment analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating in a research report issued on Monday, MarketBeat reports. They presently have a $11.00 price objective on the utilities provider’s stock, down from their prior price objective of $17.50. BMO Capital Markets’ price objective indicates a potential upside of 41.21% from the stock’s current price.
A number of other research firms also recently weighed in on
AQN. Wells Fargo & Company reduced their target price on Algonquin Power
& Utilities from $16.00 to $13.00 and set an “equal weight” rating on the
stock in a report on Wednesday, October 19th. StockNews.com assumed coverage on
Algonquin Power & Utilities in a report on Wednesday, October 12th. They
set a “sell” rating on the stock. Credit Suisse Group upgraded Algonquin Power
& Utilities from a “neutral” rating to an “outperform” rating and set a
$15.00 target price on the stock in a report on Tuesday, October 11th. Finally,
National Bank Financial upgraded Algonquin Power & Utilities from a “sector
perform” rating to an “outperform” rating and reduced their target price for
the stock from $16.00 to $14.25 in a report on Friday, October 7th. One
research analyst has rated the stock with a sell rating, eight have assigned a
hold rating and two have given a buy rating to the company’s stock. Based on
data from MarketBeat.com, Algonquin Power & Utilities currently has an
average rating of “Hold” and an average target price of $12.47. Read
more …
Bank of America (NYSE:BAC) was downgraded by research analysts at Citigroup from a "buy" rating to a "neutral" rating in a research report issued to clients and investors on Monday, The Fly reports. They currently have a $40.00 target price on the financial services provider's stock. Citigroup's price objective indicates a potential upside of 4.14% from the company's current price.
BAC has been the topic of several other research reports.
Barclays cut their target price on Bank of America from $58.00 to $51.00 and set
an "overweight" rating on the stock in a research note on Tuesday,
July 19th. BMO Capital Markets boosted their price target on Bank of America
from $41.00 to $42.00 in a research note on Tuesday, October 18th. Morgan
Stanley dropped their price target on Bank of America from $40.00 to $36.00 and
set an "equal weight" rating on the stock in a research note on
Wednesday, October 5th. JPMorgan Chase & Co. boosted their price target on
Bank of America from $35.50 to $39.00 in a research note on Wednesday, November
2nd. Finally, StockNews.com initiated coverage on Bank of America in a research
note on Wednesday, October 12th. They set a "hold" rating on the
stock. Five equities research analysts have rated the stock with a hold rating
and nine have issued a buy rating to the company. According to data from
MarketBeat.com, the company presently has an average rating of "Moderate
Buy" and an average price target of $44.68. Read
more …
W.W. Grainger (NYSE:GWW) was downgraded by equities researchers at Wolfe Research from an “outperform” rating to a “peer perform” rating in a report released on Monday, Marketbeat.com reports.
Other analysts have also recently issued research reports
about the company. Morgan Stanley upped their price objective on W.W. Grainger
from $448.00 to $485.00 and gave the company an “underweight” rating in a
research report on Monday, October 31st. Stephens boosted their price target on
W.W. Grainger from $565.00 to $600.00 and gave the company an “equal weight”
rating in a report on Monday, August 1st. StockNews.com initiated coverage on
W.W. Grainger in a report on Wednesday, October 12th. They set a “buy” rating
for the company. Royal Bank of Canada boosted their price target on W.W.
Grainger from $399.00 to $422.00 and gave the company an “underperform” rating
in a report on Monday, August 1st. Finally, Oppenheimer boosted their price
target on W.W. Grainger to $660.00 in a report on Tuesday, November 1st. Two
equities research analysts have rated the stock with a sell rating, four have
given a hold rating and three have given a buy rating to the company’s stock.
According to MarketBeat.com, W.W. Grainger has a consensus rating of “Hold” and
an average target price of $572.83. Read
more …
Essex Property Trust (NYSE:ESS) was downgraded by research analysts at Bank of America from a “buy” rating to a “neutral” rating in a note issued to investors on Monday, MarketBeat.com reports. They currently have a $233.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $265.00. Bank of America‘s price objective would suggest a potential upside of 9.81% from the company’s previous close.
Other analysts have also recently issued reports about the
company. Raymond James reissued an “upgrade” rating and set a $300.00 target
price on shares of Essex Property Trust in a research note on Thursday, August
4th. Evercore ISI decreased their price target on shares of Essex Property
Trust to $290.00 in a research note on Thursday, October 13th. The Goldman
Sachs Group decreased their price target on shares of Essex Property Trust from
$333.00 to $284.00 and set a “buy” rating for the company in a research note on
Tuesday, October 18th. Piper Sandler cut shares of Essex Property Trust from an
“overweight” rating to a “neutral” rating and decreased their price target for
the stock from $297.00 to $250.00 in a research note on Friday, October 28th.
Finally, Barclays decreased their price target on shares of Essex Property
Trust from $300.00 to $219.00 and set an “underweight” rating for the company
in a research note on Thursday, November 10th. Three investment analysts have
rated the stock with a sell rating, ten have given a hold rating and seven have
issued a buy rating to the company. According to MarketBeat, the stock
currently has an average rating of “Hold” and an average target price of
$279.11. Read
more …
Omega Healthcare Investors (NYSE:OHI) was downgraded by equities researchers at Bank of America from a "buy" rating to a "neutral" rating in a report released on Monday, The Fly reports. They presently have a $33.00 target price on the real estate investment trust's stock, down from their prior target price of $35.00. Bank of America's target price suggests a potential upside of 2.39% from the stock's current price.
A number of other analysts also recently issued reports on
the stock. Raymond James lifted their price objective on shares of Omega
Healthcare Investors from $34.00 to $35.00 and gave the company an
"outperform" rating in a report on Wednesday, November 9th. Robert W.
Baird downgraded shares of Omega Healthcare Investors from an
"outperform" rating to a "neutral" rating and set a $30.00
price objective on the stock. in a report on Monday, October 10th.
StockNews.com initiated coverage on shares of Omega Healthcare Investors in a
report on Wednesday, October 12th. They issued a "hold" rating on the
stock. Finally, Truist Financial boosted their target price on shares of Omega
Healthcare Investors from $30.00 to $34.00 and gave the stock a
"hold" rating in a report on Tuesday, September 13th. Eight research
analysts have rated the stock with a hold rating and one has given a buy rating
to the stock. Based on data from MarketBeat, the company has a consensus rating
of "Hold" and an average price target of $31.33. Read
more …
LyondellBasell Industries (NYSE:LYB) was downgraded by equities researchers at Mizuho from a “buy” rating to a “neutral” rating in a research note issued on Monday, MarketBeat reports. They presently have a $88.00 target price on the specialty chemicals company’s stock. Mizuho’s price target suggests a potential upside of 3.19% from the stock’s previous close.
Several other equities analysts have also recently weighed
in on LYB. Bank of America dropped their price objective on LyondellBasell
Industries from $95.00 to $77.00 in a research note on Tuesday, October 11th.
Royal Bank of Canada decreased their target price on LyondellBasell Industries
from $99.00 to $97.00 and set a “sector perform” rating for the company in a
research report on Tuesday, August 2nd. Wells Fargo & Company decreased
their target price on LyondellBasell Industries from $95.00 to $90.00 and set
an “overweight” rating for the company in a research report on Tuesday,
November 1st. JPMorgan Chase & Co. lowered LyondellBasell Industries from
an “overweight” rating to a “neutral” rating and decreased their target price
for the company from $115.00 to $80.00 in a research report on Friday,
September 2nd. Finally, Morgan Stanley decreased their target price on
LyondellBasell Industries from $115.00 to $100.00 and set an “overweight”
rating for the company in a research report on Wednesday, October 12th. Four
analysts have rated the stock with a sell rating, twelve have assigned a hold
rating and four have assigned a buy rating to the stock. According to
MarketBeat.com, the stock presently has an average rating of “Hold” and an
average price target of $93.00. Read
more …
Westlake (NYSE:WLK) was downgraded by research analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a research note issued to investors on Tuesday, The Fly reports.
WLK has been the topic of a number of other research
reports. Bank of America dropped their target price on shares of Westlake from
$130.00 to $120.00 in a report on Tuesday, October 11th. Royal Bank of Canada
upped their price target on shares of Westlake from $107.00 to $113.00 and gave
the stock an "outperform" rating in a research note on Monday,
November 7th. UBS Group upgraded shares of Westlake from a "sell"
rating to a "neutral" rating and upped their price target for the
stock from $92.00 to $95.00 in a research note on Thursday, October 6th.
StockNews.com cut shares of Westlake from a "buy" rating to a
"hold" rating in a research note on Sunday, November 6th. Finally,
Morgan Stanley dropped their price target on shares of Westlake from $115.00 to
$110.00 and set an "equal weight" rating on the stock in a research
note on Monday, November 7th. Three analysts have rated the stock with a sell
rating, eight have issued a hold rating and four have issued a buy rating to
the company. According to MarketBeat.com, Westlake presently has an average
rating of "Hold" and a consensus target price of $111.29. Read
more …
Texas Instruments (NASDAQ:TXN) was downgraded by Credit Suisse Group from an "outperform" rating to a "neutral" rating in a research note issued to investors on Wednesday, Briefing.com reports. They currently have a $205.00 price objective on the semiconductor company's stock, up from their previous price objective of $185.00. Credit Suisse Group's price target suggests a potential upside of 15.45% from the stock's previous close.
TXN has been the topic of a number of other research
reports. Susquehanna reduced their price target on Texas Instruments from
$215.00 to $195.00 in a research report on Wednesday, October 26th. Barclays
raised Texas Instruments from an "underweight" rating to an
"equal weight" rating and set a $150.00 price target on the stock in
a research report on Monday, October 24th. Citigroup reduced their price target
on Texas Instruments from $165.00 to $155.00 and set a "neutral"
rating on the stock in a research report on Wednesday, October 26th.
Oppenheimer reduced their price target on Texas Instruments from $200.00 to
$185.00 and set an "outperform" rating on the stock in a research report
on Friday, October 21st. Finally, Benchmark cut their target price on Texas
Instruments from $205.00 to $189.00 and set a "buy" rating on the
stock in a research report on Wednesday, October 26th. One research analyst has
rated the stock with a sell rating, sixteen have given a hold rating and eight
have assigned a buy rating to the company's stock. According to data from
MarketBeat.com, the company currently has an average rating of "Hold"
and a consensus target price of $174.70. Read
more …
Magellan Midstream Partners (NYSE:MMP) was downgraded by Wolfe Research from a "peer perform" rating to an "underperform" rating in a report released on Wednesday, The Fly reports. They presently have a $49.00 price objective on the pipeline company's stock. Wolfe Research's price target would indicate a potential downside of 5.88% from the company's previous close.
A number of other analysts have also weighed in on MMP.
StockNews.com began coverage on Magellan Midstream Partners in a research note
on Wednesday, October 12th. They issued a "hold" rating for the
company. Royal Bank of Canada raised their price objective on shares of
Magellan Midstream Partners from $58.00 to $59.00 and gave the company an
"outperform" rating in a research report on Tuesday, November 1st.
Mizuho upped their target price on shares of Magellan Midstream Partners from
$52.00 to $53.00 and gave the stock a "neutral" rating in a research
report on Friday, October 28th. TD Securities raised their price target on
shares of Magellan Midstream Partners from $52.00 to $54.00 and gave the
company a "hold" rating in a report on Friday, October 28th. Finally,
Raymond James boosted their price objective on shares of Magellan Midstream
Partners from $54.00 to $55.00 and gave the stock an "outperform"
rating in a research report on Friday, October 28th. Three analysts have rated
the stock with a sell rating, four have given a hold rating and five have
issued a buy rating to the company's stock. Based on data from MarketBeat, the
company has a consensus rating of "Hold" and a consensus target price
of $54.55. Read
more …
Medtronic (NYSE:MDT) was downgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating in a research note issued to investors on Wednesday, The Fly reports.
Several other brokerages have also recently issued reports
on MDT. TheStreet cut shares of Medtronic from a "b-" rating to a
"c+" rating in a report on Monday, August 1st. Truist Financial cut
their price objective on Medtronic from $97.00 to $89.00 and set a
"hold" rating for the company in a report on Monday, October 17th.
Citigroup lowered their target price on Medtronic from $110.00 to $108.00 in a
report on Wednesday, October 5th. Raymond James cut Medtronic from an
"outperform" rating to a "market perform" rating in a
research report on Wednesday, August 24th. Finally, Wells Fargo & Company
reduced their price target on shares of Medtronic from $104.00 to $96.00 and
set an "equal weight" rating for the company in a research report on
Wednesday, August 24th. One investment analyst has rated the stock with a sell
rating, fourteen have given a hold rating and nine have assigned a buy rating
to the company. According to data from MarketBeat, Medtronic currently has a
consensus rating of "Hold" and a consensus target price of $108.25. Read
more …
Unum Group (NYSE:UNM) was downgraded by stock analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report released on Wednesday, MarketBeat reports. They presently have a $50.00 price target on the financial services provider’s stock. The Goldman Sachs Group’s price objective would indicate a potential upside of 22.22% from the company’s current price.
UNM has been the subject of several other research reports.
Barclays raised their price target on shares of Unum Group from $36.00 to
$43.00 and gave the stock an “underweight” rating in a research note on Sunday,
November 6th. StockNews.com initiated coverage on shares of Unum Group in a research
note on Wednesday, October 12th. They set a “hold” rating for the company.
Morgan Stanley raised their price target on shares of Unum Group from $41.00 to
$45.00 and gave the stock an “equal weight” rating in a research note on
Wednesday, November 2nd. Truist Financial raised their price target on shares
of Unum Group from $44.00 to $48.00 and gave the stock a “buy” rating in a
research note on Friday, October 7th. Finally, Credit Suisse Group raised their
price target on shares of Unum Group from $21.00 to $37.00 and gave the stock a
“neutral” rating in a research note on Thursday, August 18th. One investment
analyst has rated the stock with a sell rating, ten have assigned a hold rating
and one has given a buy rating to the company’s stock. According to MarketBeat,
Unum Group currently has a consensus rating of “Hold” and an average target
price of $39.60. Read
more …
Home Depot (NYSE:HD) was downgraded by Raymond James from an “outperform” rating to a “market perform” rating in a report released on Wednesday, Marketbeat.com reports.
A number of other analysts have also weighed in on the
stock. JPMorgan Chase & Co. cut their target price on shares of Home Depot
from $347.00 to $300.00 in a research note on Friday, November 11th. DA
Davidson upped their target price on shares of Home Depot to $334.00 in a
research note on Monday, August 22nd. StockNews.com upgraded shares of Home
Depot from a “hold” rating to a “buy” rating in a research note on Tuesday,
November 8th. BNP Paribas lowered shares of Home Depot from an “outperform”
rating to a “neutral” rating and set a $286.00 target price on the stock. in a
research note on Wednesday, October 19th. Finally, MKM Partners cut their
target price on shares of Home Depot from $330.00 to $312.00 in a research note
on Wednesday, November 9th. Six equities research analysts have rated the stock
with a hold rating and twenty have given a buy rating to the stock. According
to MarketBeat.com, Home Depot currently has a consensus rating of “Moderate
Buy” and a consensus price target of $346.29. Read
more …
Norfolk Southern (NYSE:NSC) was downgraded by Wolfe Research from an "outperform" rating to a "peer perform" rating in a research note issued to investors on Thursday, The Fly reports.
A number of other analysts have also recently weighed in on
NSC. TD Securities cut shares of Norfolk Southern from a "buy" rating
to a "hold" rating in a research note on Thursday, October 13th.
Credit Suisse Group lifted their price target on shares of Norfolk Southern
from $264.00 to $267.00 and gave the stock an "outperform" rating in
a research note on Thursday, October 27th. Deutsche Bank Aktiengesellschaft
reduced their price objective on shares of Norfolk Southern from $230.00 to
$220.00 in a report on Thursday, October 27th. The Goldman Sachs Group dropped
their target price on Norfolk Southern from $286.00 to $255.00 and set a
"buy" rating on the stock in a report on Monday, October 10th.
Finally, Susquehanna upped their target price on Norfolk Southern from $218.00
to $220.00 in a research report on Thursday, October 27th. One analyst has
rated the stock with a sell rating, eleven have given a hold rating and six
have issued a buy rating to the company. Based on data from MarketBeat.com, the
company currently has a consensus rating of "Hold" and a consensus
price target of $243.10. Read
more …
Hershey (NYSE:HSY) was downgraded by Erste Group Bank from a "buy" rating to a "hold" rating in a research note issued to investors on Friday, The Fly reports.
A number of other brokerages also recently issued reports on
HSY. Cowen initiated coverage on shares of Hershey in a report on Wednesday,
September 14th. They issued a "market perform" rating and a $238.00
price target on the stock. Morgan Stanley lifted their price target on shares
of Hershey from $222.00 to $224.00 and gave the stock an "equal
weight" rating in a research note on Tuesday, November 8th. Exane BNP
Paribas began coverage on shares of Hershey in a research report on Tuesday.
They issued a "neutral" rating and a $235.00 price objective for the
company. Cowen began coverage on shares of Hershey in a research report on
Wednesday, September 14th. They issued a "market perform" rating and
a $238.00 price objective for the company. Finally, BNP Paribas began coverage
on shares of Hershey in a research report on Tuesday. They issued a
"neutral" rating and a $235.00 price objective for the company. Ten
analysts have rated the stock with a hold rating and eight have assigned a buy
rating to the stock. According to MarketBeat.com, the stock currently has an
average rating of "Hold" and a consensus target price of $229.00. Read
more …
Comments
Post a Comment